Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis.
Vincenzo
V
Savini
Chiara
C
Catavitello
Marianna
M
D'Aloisio
Andrea
A
Balbinot
Daniela
D
Astolfi
Gioviana
G
Masciarelli
Arianna
A
Pompilio
Giovanni
G
Di Bonaventura
Domenico
D
D'Antonio
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001437:Bacteriuria / Q000209:etiology / Q000382:microbiology; D018441:Biofilms; D055499:Catheter-Related Infections / Q000188:drug therapy* / Q000382:microbiology; D002701:Chloramphenicol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004198:Disease Susceptibility; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D004359:Drug Therapy, Combination; D004866:Equipment Contamination; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans; D055728:Primary Myelofibrosis / Q000150:complications*; D012293:Rifampin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D020615:Stenotrophomonas maltophilia / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification / Q000276:immunology; D014546:Urinary Catheterization / Q000009:adverse effects*; D016055:Urinary Retention / Q000209:etiology / Q000628:therapy
D000900:Anti-Bacterial Agents; D002701:Chloramphenicol; D012293:Rifampin